ARTV $0.00 ( 0.00%) Quote details

stock

Artiva Biotherapeutics, Inc. Common Stock

NASDAQ | ARTV

2.03

USD

0.00 ( 0.00%)

AT CLOSE (AS OF May 16, 2025)

$49M

MARKET CAP

-

P/E Ratio

-6.04

EPS

$17

52 Week High

$1.8

52 Week Low

LIFE SCIENCES

Sector

ARTV Chart

Price Action Signals for ARTV

Trade Smarter

Automate your trading workflow with powerful tools — built for serious traders.

Icon For Time-schedule

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Icon For Search

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Icon For Clipboard-list

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

ARTV Technicals

Tags:

ARTV Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $251K
Total Revenue $251K
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$67M
Selling General And Administrative $17M
Research And Development $50M
Operating Expenses $68M
Investment Income Net -
Net Interest Income $5.3M
Interest Income $5.3M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2.4M
Income Before Tax -$58M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$58M
Comprehensive Income Net Of Tax -
Ebit -$67M
Ebitda -$65M
Net Income -$58M

Revenue & Profitability

Earnings Performance

ARTV Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $210M
Total Current Assets $189M
Cash And Cash Equivalents At Carrying Value $40M
Cash And Short Term Investments $40M
Inventory -
Current Net Receivables $146K
Total Non Current Assets $21M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $145M
Other Current Assets $3.1M
Other Non Current Assets -
Total Liabilities $23M
Total Current Liabilities $12M
Current Accounts Payable $1.1M
Deferred Revenue -
Current Debt -
Short Term Debt $3.7M
Total Non Current Liabilities $11M
Capital Lease Obligations $14M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $14M
Other Current Liabilities $7.4M
Other Non Current Liabilities $73K
Total Shareholder Equity $187M
Treasury Stock -
Retained Earnings -$247M
Common Stock $3K
Common Stock Shares Outstanding $11M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$55M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $2.4M
Capital Expenditures $642K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $162M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$4.2M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$65M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $251K
Total Revenue $251K
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$67M
Selling General And Administrative $17M
Research And Development $50M
Operating Expenses $68M
Investment Income Net -
Net Interest Income $5.3M
Interest Income $5.3M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2.4M
Income Before Tax -$58M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$58M
Comprehensive Income Net Of Tax -
Ebit -$67M
Ebitda -$65M
Net Income -$58M

ARTV News

ARTV Profile

Artiva Biotherapeutics, Inc. Common Stock Profile

Sector: LIFE SCIENCES

Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

None

AFMD
227.85%
$0.279
HCTI
-78.99%
$0.0079
PLRZ
-25.84%
$0.0066
BON
22.46%
$0.0638
PLUG
10.44%
$0.7724
NVDA
0.42%
$135.4
IXHL
-3.17%
$0.26
CGBS
-24.07%
$0.0694
GORV
56.50%
$0.2191
VSTE
17.33%
$0.1564
AGMH
11.67%
$0.067
UOKA
12.58%
$0.0922
ONCO
13.54%
$0.0847
GNLN
-3.13%
$0.0062
LCID
5.58%
$2.84
NCNA
-17.98%
$0.0438
QBTS
11.06%
$12.25
SPCE
43.28%
$4.8
SMCI
4.98%
$46.15
SHOP
0.49%
$110.75
TSLA
2.09%
$349.98
QUBT
39.29%
$12.87
LGMK
-2.26%
$0.013
APLD
22.18%
$6.83
KLTO
14.01%
$0.2246
COIN
9.01%
$266.46
ACHR
9.11%
$13.3
UNH
6.40%
$291.91
RGTI
2.69%
$11.85
AXDX
-61.36%
$0.034
F
0.47%
$10.8
AMST
50.00%
$3.36
VHAI
-16.67%
$0.0005
SOFI
2.58%
$13.92
DNN
-4.67%
$1.43
PLTR
1.09%
$129.52
INTC
0.51%
$21.66
AAPL
-0.09%
$211.26
LYT
-16.78%
$0.0982
HIMS
10.36%
$64.65
VOR
3.51%
$0.1769
INZY
178.17%
$3.95
BAC
0.70%
$44.69
AAL
0.85%
$11.86
GRYP
29.91%
$1.39
DGLY
-1.48%
$0.04
BDSX
36.91%
$0.3012
AMD
1.90%
$117.17
AMZN
0.20%
$205.59
CRWV
22.09%
$80.3
GOOGL
1.36%
$166.19
WULF
10.51%
$3.89
AUR
-1.76%
$6.7
ITUB
1.20%
$6.72
MARA
3.38%
$16.21
NFE
5.98%
$2.66
TLRY
12.50%
$0.495
PFE
1.02%
$22.83
RIOT
5.17%
$9.15
GOOG
1.23%
$167.43
BTG
0.34%
$2.95
RIG
-1.88%
$2.61
AIRE
-17.26%
$0.5771
SENS
-3.60%
$0.53
WMT
1.96%
$98.24
QS
11.03%
$4.73
WBD
0.22%
$9.16
BBD
0.37%
$2.74
RIVN
3.33%
$15.81
DFS
-0.21%
$200.05
T
1.43%
$27.72
MULN
10.47%
$0.1699
SNAP
1.98%
$8.75
NGD
-2.33%
$3.77
MLGO
-8.08%
$1.65
CSCO
-1.00%
$63.62
CLSK
4.49%
$9.78
ME
-21.26%
$0.6063
CUTR
-10.19%
$0.0969
FUBO
8.81%
$3.21
CDE
0.67%
$7.46
TSSI
74.07%
$15.44
SOUN
1.63%
$11.19
GGB
1.44%
$2.81
AMC
4.98%
$2.95
CAN
4.20%
$0.7933
NIO
2.76%
$4.1
IREN
8.52%
$8.41
BITF
7.48%
$1.15
GRAB
0.59%
$5.09
FSM
-0.92%
$5.39
HOOD
1.78%
$61.76
RKLB
1.39%
$25.57
CIFR
21.77%
$3.86
BTBT
15.53%
$2.38
MSFT
0.25%
$454.27
LYG
0.50%
$3.99
AVGO
-1.73%
$228.61
KULR
-13.51%
$1.28
RXRX
7.29%
$4.56
AFMD
227.85%
$0.279
HCTI
-78.99%
$0.0079
PLRZ
-25.84%
$0.0066
BON
22.46%
$0.0638
PLUG
10.44%
$0.7724
NVDA
0.42%
$135.4
IXHL
-3.17%
$0.26
CGBS
-24.07%
$0.0694
GORV
56.50%
$0.2191
VSTE
17.33%
$0.1564
AGMH
11.67%
$0.067
UOKA
12.58%
$0.0922
ONCO
13.54%
$0.0847
GNLN
-3.13%
$0.0062
LCID
5.58%
$2.84
NCNA
-17.98%
$0.0438
QBTS
11.06%
$12.25
SPCE
43.28%
$4.8
SMCI
4.98%
$46.15
SHOP
0.49%
$110.75
TSLA
2.09%
$349.98
QUBT
39.29%
$12.87
LGMK
-2.26%
$0.013
APLD
22.18%
$6.83
KLTO
14.01%
$0.2246
COIN
9.01%
$266.46
ACHR
9.11%
$13.3
UNH
6.40%
$291.91
RGTI
2.69%
$11.85
AXDX
-61.36%
$0.034
F
0.47%
$10.8
AMST
50.00%
$3.36
VHAI
-16.67%
$0.0005
SOFI
2.58%
$13.92
DNN
-4.67%
$1.43
PLTR
1.09%
$129.52
INTC
0.51%
$21.66
AAPL
-0.09%
$211.26
LYT
-16.78%
$0.0982
HIMS
10.36%
$64.65
VOR
3.51%
$0.1769
INZY
178.17%
$3.95
BAC
0.70%
$44.69
AAL
0.85%
$11.86
GRYP
29.91%
$1.39
DGLY
-1.48%
$0.04
BDSX
36.91%
$0.3012
AMD
1.90%
$117.17
AMZN
0.20%
$205.59
CRWV
22.09%
$80.3
GOOGL
1.36%
$166.19
WULF
10.51%
$3.89
AUR
-1.76%
$6.7
ITUB
1.20%
$6.72
MARA
3.38%
$16.21
NFE
5.98%
$2.66
TLRY
12.50%
$0.495
PFE
1.02%
$22.83
RIOT
5.17%
$9.15
GOOG
1.23%
$167.43
BTG
0.34%
$2.95
RIG
-1.88%
$2.61
AIRE
-17.26%
$0.5771
SENS
-3.60%
$0.53
WMT
1.96%
$98.24
QS
11.03%
$4.73
WBD
0.22%
$9.16
BBD
0.37%
$2.74
RIVN
3.33%
$15.81
DFS
-0.21%
$200.05
T
1.43%
$27.72
MULN
10.47%
$0.1699
SNAP
1.98%
$8.75
NGD
-2.33%
$3.77
MLGO
-8.08%
$1.65
CSCO
-1.00%
$63.62
CLSK
4.49%
$9.78
ME
-21.26%
$0.6063
CUTR
-10.19%
$0.0969
FUBO
8.81%
$3.21
CDE
0.67%
$7.46
TSSI
74.07%
$15.44
SOUN
1.63%
$11.19
GGB
1.44%
$2.81
AMC
4.98%
$2.95
CAN
4.20%
$0.7933
NIO
2.76%
$4.1
IREN
8.52%
$8.41
BITF
7.48%
$1.15
GRAB
0.59%
$5.09
FSM
-0.92%
$5.39
HOOD
1.78%
$61.76
RKLB
1.39%
$25.57
CIFR
21.77%
$3.86
BTBT
15.53%
$2.38
MSFT
0.25%
$454.27
LYG
0.50%
$3.99
AVGO
-1.73%
$228.61
KULR
-13.51%
$1.28
RXRX
7.29%
$4.56
Discover more tools and features to empower your trading
Explore Features

Quotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.